Mehmet Hilmi Doğu
Mehmet Hilmi Doğu publishes mostly in Hematology, Genetics and Oncology, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Acute Myeloid Leukemia Research.
- World rank
- #7,495,139 of 7,710,434 ranked researchers
- Rank in Türkiye
- #108,968 of 117,622
- Works
- 128
- Citations
- 737
- Citations per work
- 5.8
What does Mehmet Hilmi Doğu research?
Mehmet Hilmi Doğu's work is mostly in Medicine (56%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7256.4%
- Medicine7256.4%
- Everything else5038.9%
- Life Sciences64.7%
- 1Hematology19% of their works
- 2Genetics12% of their works
- 3Oncology10% of their works
- 4Pathology and Forensic Medicine10% of their works
- 5Neurology5% of their works
- 6Immunology5% of their works
Research topics
Which keywords describe Mehmet Hilmi Doğu's research?
The keywords of their largest research topics: Rituximab, Prognostic Factors, Classification, Lymphoma, Minimal Residual Disease, Acute Myeloid Leukemia, AML and Chronic Lymphocytic Leukemia.
- Acute Lymphoblastic Leukemia
- Platelets
- JAK2 Mutation
- BCR-ABL
- Diagnosis Criteria
- Chronic Lymphocytic Leukemia
- AML
- Lymphoma
- Prognostic Factors
- Rituximab
- Classification
- Minimal Residual Disease
- Acute Myeloid Leukemia
- Genomic Aberrations
- International Myeloma Working Group
- Imatinib
- Myelofibrosis
- Thrombosis
- Childhood Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Rituximab472 topics
- Prognostic Factors433 topics
- Classification311 topic
- Lymphoma311 topic
- Minimal Residual Disease262 topics
- AML161 topic
- Acute Myeloid Leukemia161 topic
- Chronic Lymphocytic Leukemia161 topic
- Genomic Aberrations161 topic
- Diagnosis Criteria151 topic
- International Myeloma Working Group151 topic
- BCR-ABL131 topic
- Imatinib131 topic
- JAK2 Mutation131 topic
- Myelofibrosis131 topic
- Platelets121 topic
- Thrombosis121 topic
- Acute Lymphoblastic Leukemia111 topic
- Childhood Cancer111 topic
Where does Mehmet Hilmi Doğu work?
Mehmet Hilmi Doğu's main affiliation in the publication record is Sağlık Bilimleri Üniversitesi, Türkiye.
How many publications and citations does Mehmet Hilmi Doğu have?
OpenAlex counts 128 works and 737 citations for Mehmet Hilmi Doğu, an h-index of 13, ranking #7,495,139 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mehmet Hilmi Doğu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.